Researchers identified how the poxvirus protein VITF-3 forms a molecular ring that clamps onto DNA with viral RNA polymerase, ...

Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University ...

GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B: London, UK Friday, February 27, 2026, 09:00 Hrs [IST] ...

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

Buc-ee's filed a lawsuit against the parent company of Ohio convenience store Mickey Mart, claiming the store's moose logo is ...

Researchers shamelessly copy viral strategies to get mRNA medicines into cells in one piece (Illustration courtesy of Joe Luciani ...

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated ...

Viral infections remain a significant global health challenge, as exemplified by recent pandemics. The complexity of virus-host interplay poses major ...

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated Mid-2026 BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuti ...

for victims, said Rodrigo Duterte “created clones of himself,” converting millions of peace-loving citizens into believers that violence and killings are valid solutions to societal problems. It is ...

A technical report issued by partner IntraMont Technologies in late 2025, combined with the final signed report from the ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal, ...

Merck , known as MSD outside of the United States and Canada, today announced the presentation of results from three pivotal Phase 3 trials evaluating the investigational, once-daily, oral, two-drug ...